What is XENE's dilution risk score?

XENE has a latest available DilutionScore record of 25/100, categorized as low dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for XENE, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for XENE?

DilutionWatch tracks 25 SEC filing types for XENE including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect XENE shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For XENE, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for XENE tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for XENE. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

XENE Dilution Risk Score: 25/100 (LOW)

Score Breakdown

📋 Offering Ability

46

💰 Cash Runway

0

📊 Float Risk

5

⚠️ Warrant Exposure

15

🔄 Convertible Debt

15

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 9%

💰 Capital Raise model 18%

• Active ATM program with $400M remaining capacity

🔔 Track XENE — Get forecast alerts →

Market Data

Market Cap$5.29B

Shares Outstanding96.84M

Float90.77M

Cash$930.69M

Debt$26.57M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 32.7% shares (2026Q1 vs prior)

297 institutional holders · 116.28M shares

#1 Avoro Capital Advisors LLC 11.20M shares

#2 FMR LLC 10.82M shares

#3 JANUS HENDERSON GROUP PLC 8.35M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.38M

Days to Cover7.3

% of Float5.9%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30

xbrl XBRL CONVERTIBLE 2014-12-31

4 INSIDER TRANSACTION 2026-03-13

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual XENE Dilution Snapshot

Xenon Pharmaceuticals Inc. (XENE) has a DilutionScore of 25/100, rated Low dilution risk. Score date: August 28, 2026.

Stored ATM program remaining capacity: $400.0M.
Recent SEC activity tracked for XENE: xbrl on 2026-06-30; 4 on 2026-03-13; 4 on 2026-03-13.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.